{"id":72020,"date":"2026-03-16T19:51:09","date_gmt":"2026-03-16T23:51:09","guid":{"rendered":"https:\/\/www.imperialcrs.com\/blog\/?p=72020"},"modified":"2026-03-16T19:51:09","modified_gmt":"2026-03-16T23:51:09","slug":"sustainability-in-action-esg-and-clinical-research","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/","title":{"rendered":"Sustainability in Action: ESG and Clinical Research"},"content":{"rendered":"<div>\n<p>Sustainability has become a top priority for businesses and now shapes how they are evaluated and trusted. Companies in every industry are judged not only on their results and profits, but also on how they operate. In life sciences, using sustainable practices in clinical trials is an important factor when sponsors and CROs pick their partners and service providers. ESG, which stands for <strong>Environmental, Social, and Governance<\/strong>, provides organizations with a framework for measuring these efforts and setting clear standards for accountability.<\/p>\n<\/div>\n<h2>ESG in Clinical Research Is Now an Expectation, Not an Option<\/h2>\n<p>Sustainability has become a strategic necessity that belongs at the center of every organization\u2019s operations and long-term planning, driven by both ethical responsibility and financial performance. Today\u2019s workforce increasingly seeks purpose-driven employers that demonstrate genuine environmental commitment, with a strong majority of job seekers viewing sustainable companies as more attractive places to work.<\/p>\n<p>Consumers are also aligning their spending habits with values, showing a clear willingness to support and even pay more for environmentally responsible brands. At the same time, global governments, investors, employees, and customers are calling for greater corporate accountability, particularly in addressing climate change.<\/p>\n<p>While ESG may be another acronym in an industry full of them, it carries real weight. It influences investor confidence, talent attraction and retention, supplier selection, and long-term success. Increasingly, it also shapes how sponsors and CROs evaluate their partners.<\/p>\n<h3>What ESG Encompasses<\/h3>\n<p>ESG standards evaluate companies across three core pillars:<\/p>\n<h4>Environmental \u2013 Impact on the Planet<\/h4>\n<ul>\n<li>Greenhouse gas emissions and pollution control<\/li>\n<li>Energy usage and efficiency<\/li>\n<li>Waste reduction and recycling<\/li>\n<li>Sustainable sourcing practices<\/li>\n<li>Environmental policies and measurable goals<\/li>\n<\/ul>\n<h4>Social \u2013 Impact on People<\/h4>\n<ul>\n<li>Diversity, equity, and inclusion initiatives<\/li>\n<li>Employee health and safety<\/li>\n<li>Human rights protections<\/li>\n<li>Fair labor practices and wages<\/li>\n<li>Community engagement and charitable efforts<\/li>\n<\/ul>\n<h4>Governance \u2013 How a Company Operates<\/h4>\n<ul>\n<li>Ethical business conduct<\/li>\n<li>Leadership accountability<\/li>\n<li>Executive oversight and transparency<\/li>\n<li>Risk mitigation practices<\/li>\n<li>Compliance frameworks<\/li>\n<\/ul>\n<p>By prioritizing ESG criteria, companies can mitigate risks, attract top talent, and ensure long-term profitability. In clinical research, sponsors and CROs are now incorporating ESG factors into vendor qualification, RFPs, and capability assessments. Even when sustainability isn&#8217;t the primary focus, teams often integrate it into operational due diligence.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-72042 alignnone\" src=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1.png\" alt=\"\" width=\"579\" height=\"353\" srcset=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1.png 1345w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1-300x183.png 300w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1-1024x625.png 1024w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1-768x469.png 768w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1-1170x714.png 1170w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/ESG-in-clinical-research-2-1-585x357.png 585w\" sizes=\"auto, (max-width: 579px) 100vw, 579px\" \/><\/p>\n<h2>Putting ESG to the Test<\/h2>\n<p>Imperial takes its role as a <a href=\"https:\/\/www.imperialcrs.com\/about\/corporate-responsibility\/\">corporate citizen<\/a> seriously and has long maintained policies and procedures aligned with these principles. In recent years, we have worked intentionally to formalize, document, and strengthen them, ensuring they are measurable, transparent, and aligned with the expectations of the global sponsors and CROs we support.<\/p>\n<p>To benchmark our efforts, Imperial again participated in an independent evaluation through EcoVadis, a Paris-based global sustainability ratings provider widely recognized for its rigorous methodology.<\/p>\n<h2>EcoVadis Bronze Medal Recognition for 2026<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-72050 alignright\" src=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026.png\" alt=\"\" width=\"222\" height=\"222\" srcset=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026.png 1667w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-300x300.png 300w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-1024x1024.png 1024w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-150x150.png 150w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-768x768.png 768w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-1536x1536.png 1536w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-1170x1170.png 1170w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/medal-2026-585x585.png 585w\" sizes=\"auto, (max-width: 222px) 100vw, 222px\" \/><\/p>\n<p>We are proud to share that Imperial has been awarded the EcoVadis Bronze Medal for 2026.<\/p>\n<p>This recognition places Imperial among the <strong>top 35% of companies evaluated globally<\/strong> by EcoVadis in our category. It reflects measurable progress across key sustainability performance indicators. The rating also shows that Imperial\u2019s performance aligns with top-tier sustainability practices worldwide.<\/p>\n<p>The EcoVadis assessment evaluates 21 sustainability criteria across core themes:<\/p>\n<ul>\n<li><strong>Environment:<\/strong> Reducing energy consumption, demonstrating water stewardship, and implementing environmental policies<\/li>\n<li><strong>Labor &amp; Human Rights:<\/strong> Employee health and safety, diversity and inclusion benchmarks, fair labor practices, and human rights due diligence processes<\/li>\n<li><strong>Ethics:<\/strong> Anti-corruption training, data protection practices, whistleblower mechanisms, and formal compliance policies<\/li>\n<li><strong>Sustainable Procurement: <\/strong>Supplier ESG screening rates, adopting a supplier code of conduct, supply chain risk assessments, and responsible sourcing documentation<\/li>\n<\/ul>\n<p>The assessment process is comprehensive and includes extensive documentation review, policy validation, and evidence-based scoring. It also provides invaluable insights in the form of a detailed roadmap for continuous improvement, identifying areas where stronger data tracking, formalized policies, or expanded supplier engagement can enhance performance in the coming year.<\/p>\n<h2>Why Independent Benchmarking of ESG Matters in Clinical Research<\/h2>\n<p>Sustainability claims without verification carry little weight. Independent benchmarking provides credibility, accountability, and comparability.<\/p>\n<p>EcoVadis also functions as a secure information-sharing platform. For example, clients and prospective partners can access <a href=\"https:\/\/recognition.ecovadis.com\/3WPaQ2iq70WN55a0wlyI1w\">Imperial\u2019s scorecard<\/a> directly, reducing RFIs and increasing transparency.<\/p>\n<p>In life sciences, especially, ESG performance increasingly influences supplier selection. Large pharmaceutical companies and global CROs expect measurable sustainability commitments from their partners.<\/p>\n<h2>ESG in Action at Imperial<\/h2>\n<p>Sometimes, sustainability shows up in small but meaningful decisions. At industry conferences, for example, we evaluated the traditional promotional giveaways \u2014 often single-use plastic items \u2014 and chose a more responsible alternative.<\/p>\n<p>Instead of disposable gadgets, we distribute \u201csecond life\u201d giveaways, such as plantable seed pencils and bamboo eco-friendly planter kits. The response has been overwhelmingly positive. More importantly, it aligns our brand presence with our values.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-72045 alignnone\" src=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-example-3.png\" alt=\"\" width=\"418\" height=\"368\" srcset=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-example-3.png 527w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-example-3-300x264.png 300w\" sizes=\"auto, (max-width: 418px) 100vw, 418px\" \/><\/p>\n<p>Imperial is committed to enhancing our environmental stewardship, social responsibility, and governance practices while continuing to refine our processes to achieve measurable improvements. Working together, we can make a truly lasting impact.<\/p>\n<h3>Resources<\/h3>\n<ul>\n<li>EcoVadis <a href=\"https:\/\/ecovadis.com\/\">https:\/\/ecovadis.com\/<\/a><\/li>\n<li>Sustainability in Business: What It Is and Why It Matters <a href=\"https:\/\/www.seattleu.edu\/business\/online\/albers\/blog\/what-is-sustainability-in-business\">https:\/\/www.seattleu.edu\/business\/online\/albers\/blog\/what-is-sustainability-in-business<\/a><\/li>\n<li>The Sustainability Puzzle: What Do Consumers Really Want? <a href=\"https:\/\/www.bain.com\/insights\/what-do-consumers-really-want-ceo-sustainability-guide-2024\/\">https:\/\/www.bain.com\/insights\/what-do-consumers-really-want-ceo-sustainability-guide-2024\/<\/a><\/li>\n<li>What is ESG and why does it matter for businesses? <a href=\"https:\/\/fsc.org\/en\/blog\/what-is-esg\">https:\/\/fsc.org\/en\/blog\/what-is-esg<\/a><\/li>\n<li>What is sustainability in business? <a href=\"https:\/\/www.ibm.com\/think\/topics\/business-sustainability\">https:\/\/www.ibm.com\/think\/topics\/business-sustainability<\/a><\/li>\n<\/ul>\n<div style=\"display: inline-block;\"><a class=\"rss-btn\" href=\"https:\/\/cta-service-cms2.hubspot.com\/web-interactives\/public\/v1\/track\/click?encryptedPayload=AVxigLJ9SLa2bvUwdi1tBETVQK%2B9Gmqcz49dIGJe96y8nf4%2Frf%2BIfT8tW1CFtlQZ7JW8VpsCZl3ujF7X4ytPh%2B%2BZ%2F0AHJzkApE%2B9N2vyn9%2F5O4zaeVN6mIB%2FAbWP0U1YuFF%2FQI2kgNGNa419FEOGUw8IuHE3%2B35VUlcM4%2FSml6%2FP7vNUKMa9jTALctqjR8OfSoyaJRPSmLaCm4RKAg%3D%3D&amp;portalId=47151227\" target=\"_blank\" rel=\"noopener\">Sign Up For Imperial Blog Alerts<\/a><\/div>\n<div style=\"display: inline-block; margin-left: 10px;\"><a class=\"contact-btn\" href=\"https:\/\/cta-service-cms2.hubspot.com\/web-interactives\/public\/v1\/track\/click?encryptedPayload=AVxigLIXv5GY4HUfMMix9h0VI9sOaTImjv4pgG%2B9tEb8pF0QrnPWpu7rElHRDIe6N86faZhHmihNHYYxByGLhQCBcxpZ%2Bwh7p6xtBsd%2FHfG2roid%2FRh1KknuhHB3UDk7txpRnB7k3v0chxT%2BF7rlGdwr%2FV75YbfEywhd413UaCY2fcn%2F2ELk%2B28AanVoKrjbNnoMpuP6QDSqLGNdSg%3D%3D&amp;portalId=47151227\" target=\"_blank\" rel=\"noopener\">Contact Us<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sustainability has become a top priority for businesses and now shapes how they are evaluated and trusted. Companies in every industry are judged not only on their results and profits, but also on how they operate. In life sciences, using sustainable practices in clinical trials&hellip;<\/p>\n","protected":false},"author":7,"featured_media":72048,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[23,2036,652,83,465,2061,1199,2033,1197,1889,1624,29],"class_list":["post-72020","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-insights","tag-business-partnership","tag-business-sustainability","tag-clinical-operations","tag-clinical-research","tag-clinical-research-strategies","tag-clinical-trial-vendor-selection","tag-environmental-sustainability","tag-esg","tag-sustainable-business-practices","tag-sustainable-practices-in-clinical-trials","tag-vendor-evaluation","tag-vendor-selection"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sustainability and ESG in Clinical Research Partnerships<\/title>\n<meta name=\"description\" content=\"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sustainability and ESG in Clinical Research Partnerships\" \/>\n<meta property=\"og:description\" content=\"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-16T23:51:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"797\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dan McDonald\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dan McDonald\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/\"},\"author\":{\"name\":\"Dan McDonald\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\"},\"headline\":\"Sustainability in Action: ESG and Clinical Research\",\"datePublished\":\"2026-03-16T23:51:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/\"},\"wordCount\":880,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Sustainability-and-ESG-in-clinical-research.jpg\",\"keywords\":[\"Business Partnership\",\"business sustainability\",\"Clinical Operations\",\"Clinical Research\",\"Clinical Research Strategies\",\"clinical trial vendor selection\",\"Environmental Sustainability\",\"ESG\",\"Sustainable Business Practices\",\"Sustainable Practices in Clinical Trials\",\"Vendor Evaluation\",\"Vendor Selection\"],\"articleSection\":[\"Business Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/\",\"name\":\"Sustainability and ESG in Clinical Research Partnerships\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Sustainability-and-ESG-in-clinical-research.jpg\",\"datePublished\":\"2026-03-16T23:51:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\"},\"description\":\"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Sustainability-and-ESG-in-clinical-research.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Sustainability-and-ESG-in-clinical-research.jpg\",\"width\":1200,\"height\":797},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/sustainability-in-action-esg-and-clinical-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sustainability in Action: ESG and Clinical Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\",\"name\":\"Dan McDonald\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"caption\":\"Dan McDonald\"},\"description\":\"Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/dmcdonald\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sustainability and ESG in Clinical Research Partnerships","description":"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/","og_locale":"en_US","og_type":"article","og_title":"Sustainability and ESG in Clinical Research Partnerships","og_description":"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.","og_url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2026-03-16T23:51:09+00:00","og_image":[{"width":1200,"height":797,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg","type":"image\/jpeg"}],"author":"Dan McDonald","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dan McDonald","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/"},"author":{"name":"Dan McDonald","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da"},"headline":"Sustainability in Action: ESG and Clinical Research","datePublished":"2026-03-16T23:51:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/"},"wordCount":880,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg","keywords":["Business Partnership","business sustainability","Clinical Operations","Clinical Research","Clinical Research Strategies","clinical trial vendor selection","Environmental Sustainability","ESG","Sustainable Business Practices","Sustainable Practices in Clinical Trials","Vendor Evaluation","Vendor Selection"],"articleSection":["Business Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/","url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/","name":"Sustainability and ESG in Clinical Research Partnerships","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg","datePublished":"2026-03-16T23:51:09+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da"},"description":"Discover how sustainability in clinical research and ESG are shaping how sponsors evaluate operational partners and service providers.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/03\/Sustainability-and-ESG-in-clinical-research.jpg","width":1200,"height":797},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/sustainability-in-action-esg-and-clinical-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Sustainability in Action: ESG and Clinical Research"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da","name":"Dan McDonald","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","caption":"Dan McDonald"},"description":"Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/dmcdonald\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=72020"}],"version-history":[{"count":15,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72020\/revisions"}],"predecessor-version":[{"id":72057,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72020\/revisions\/72057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/72048"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=72020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=72020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=72020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}